Would long acting anti-psychotic injections be more effective then oral anti-psychotics in relapse prevention of adult schizophrenia?
these are the sources that i would like to be used:
1. Relapse Prevention in Schizophrenia and Schizoaffective
Disorder with Risperidone Long-Acting Injectable vs
Quetiapine: Results of a Long-Term, Open-Label,
Randomized Clinical Trial
2.A Nationwide Cohort Study of Oral and
Depot Antipsychotics After First Hospitalization
for Schizophrenia
3. An Exploratory, Open-Label, Randomized Trial
Comparing Risperidone Long-Acting Injectable
with Oral Antipsychotic Medication in the
Treatment of Early Psychosis
4.Depot and oral antipsychotics:
patient preferences and attitudes
are not the same thing
5.Descriptive analyses of the aripiprazole arm in the risperidone
long-acting injectable versus quetiapine relapse prevention trial
(ConstaTRE)
6.First-generation antipsychotic long-acting
injections v. oral antipsychotics in schizophrenia:
systematic review of randomised controlled trials
and observational studies
7.Long-acting injectable paliperidone palmitate
versus oral paliperidone extended release:
a comparative analysis from two placebocontrolled
relapse prevention studies
8.Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in
Schizophrenia: A Meta-Analysis of Randomized Trials
9.Long-Acting Risperidone and Oral
Antipsychotics in Unstable Schizophrenia
10.Maintenance Treatment With Long-Acting Injectable Risperidone
in First-Episode Schizophrenia: A Randomized Effectiveness Study
11.Olanzapine Long-Acting Injection: A 24-Week,
Randomized, Double-Blind Trial of Maintenance
Treatment in Patients With Schizophrenia
12.Oral versus depot antipsychotic drugs for schizophreniaA critical
systematic review and meta-analysis of randomised long-term trials
13.Oral versus Long-Acting Injectable Antipsychotics in the
Treatment of Schizophrenia and Special Populations at Risk for
Treatment Nonadherence: A Systematic Review.